Drugs / AZD4694
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00838877 | Jan → Oct 2009 | Alzheimer disease | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD4694 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00838877 ↗ |
| Modality | Diagnostic / imaging agent | “Open Label Positron Emission Tomography Study With [18F]AZD4694 and [11C]AZD2184, Candidate Radioligands for AB Amyloid” NCT00838877 ↗ |
| Route | Intravenous | “single dose of iv. admin. 1-2 times per subject” NCT00838877 ↗ |